109 related articles for article (PubMed ID: 11769777)
1. Would you know one if you met one?
Grange JM
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1162-3. PubMed ID: 11769777
[No Abstract] [Full Text] [Related]
2. Trends in drug resistance of mycobacterium tuberculosis.
Hejny J
Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
[No Abstract] [Full Text] [Related]
3. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
[TBL] [Abstract][Full Text] [Related]
4. [Effect of saturation of Mycobacterium tuberculosis--a theoretical basis of the method of mazimum concentration of tuberculostatic preparations].
Bondarev IM
Probl Tuberk; 1974; 52(6):58-64. PubMed ID: 4211415
[No Abstract] [Full Text] [Related]
5. Studies of early bactericidal activity: new insights into isoniazid pharmacokinetics.
Gillespie SH
Clin Infect Dis; 2004 Nov; 39(10):1431-2. PubMed ID: 15546076
[No Abstract] [Full Text] [Related]
6. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
7. [Complex research studies in the testing of the effectiveness of phenaside].
Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
[No Abstract] [Full Text] [Related]
8. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
[TBL] [Abstract][Full Text] [Related]
9. [Bactericidal therapy in patients with tuberculosis].
Krasnov VA; Ursov IG
Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
[No Abstract] [Full Text] [Related]
10. Drug resistance in tuberculosis.
Ebrahim GJ
J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
[No Abstract] [Full Text] [Related]
11. Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.
Coban AY; Bilgin K; Uzun M; Tasdelen Fisgin N; Akgunes A; Cihan CC; Birinci A; Durupinar B
J Clin Microbiol; 2005 Apr; 43(4):1930-1. PubMed ID: 15815022
[TBL] [Abstract][Full Text] [Related]
12. [Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis].
Novozhilova IA
Probl Tuberk Bolezn Legk; 2004; (4):29-31. PubMed ID: 15171041
[No Abstract] [Full Text] [Related]
13. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
15. Transmission of isoniazid-resistant tuberculosis.
Borgdorff MW
J Infect Dis; 2004 Aug; 190(3):650; author reply 650-1. PubMed ID: 15243944
[No Abstract] [Full Text] [Related]
16. [Resistance and virulence of mycobacteria. Clinical and experimental studies].
Lucchesi M
Ftiziologia; 1971; 20(4):401-4. PubMed ID: 5005707
[No Abstract] [Full Text] [Related]
17. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
Koretskaia NM; Iarygina IV
Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
[TBL] [Abstract][Full Text] [Related]
18. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
Irtuganova OA; Smirnova NS; Slogotskaia LV
Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
[No Abstract] [Full Text] [Related]
19. Isoniazid activity is terminated by bacterial persistence.
Mitchison DA; Jindani A; Davies GR; Sirgel F
J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
[No Abstract] [Full Text] [Related]
20. Persistence, not resistance, is the cause of loss of isoniazid effect.
Wallis RS; Palaci M; Eisenach K
J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
